Skip to content

Lissencephaly 7 With Cerebellar Hypoplasia C4225359

Published: July 22, 2026Updated: August 25, 2026

A brain malformation affecting both the brain surface and cerebellum. It causes severe developmental delays and movement problems. Treatment focuses on supportive care and managing symptoms.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 25, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Severe developmental delay

(neurologic)

Cerebellar ataxia

(neurologic)

Generalized hypotonia

(neurologic)

Dysarthria

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Cerebellar symptom management

Pharmacological management of cerebellar symptoms including ataxia and coordination difficulties, often involving medications to improve motor control and reduce associated symptoms.

medication
2

Medication management with follow-up

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
3

Vestibular and balance rehabilitation

Specialized therapy targeting balance, coordination, and gait training to address cerebellar hypoplasia-related motor deficits through targeted exercises.

physical_therapy

Additional treatment options

Neuroimaging and neurological follow-up

Regular MRI assessments and neurological examinations to monitor cerebellar development and detect any progressive changes requiring intervention adjustment.

monitoring

Botulinum toxin injections

Local injections to manage spasticity and dystonia that may accompany cerebellar dysfunction, improving comfort and facilitating therapy.

procedure

Adaptive equipment provision

Provision of mobility aids, adaptive seating, and safety equipment to enhance independence and prevent injury during daily activities.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Lissencephaly 7 With Cerebellar Hypoplasia C4225359?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Medication Comparisons

Compare medications used to treat Lissencephaly 7 With Cerebellar Hypoplasia C4225359. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 25, 2026. · Read our editorial policy